Free Trial

Reviva Pharmaceuticals (RVPHW) Competitors

Reviva Pharmaceuticals logo
$0.06 +0.00 (+0.70%)
As of 03:14 PM Eastern

RVPHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Reviva Pharmaceuticals stock or one of its competitors? The main competitors of Reviva Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Reviva Pharmaceuticals vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Reviva Pharmaceuticals (NASDAQ:RVPHW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Reviva Pharmaceuticals N/A N/A N/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 equaled Reviva Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
Reviva Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Reviva PharmaceuticalsN/AN/AN/AN/AN/A

180 Life Sciences and Reviva Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Reviva PharmaceuticalsN/AN/A

Summary

180 Life Sciences and Reviva Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.

Get Reviva Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVPHW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVPHW vs. The Competition

MetricReviva PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.71M$5.61B$8.62B
Dividend YieldN/A3.74%5.28%4.17%
P/E RatioN/A3.3127.1419.96
Price / SalesN/A4,216.94411.83157.63
Price / CashN/A13.1938.2534.64
Price / BookN/A36.957.064.69
Net IncomeN/A-$91.56M$3.23B$248.14M
7 Day PerformanceN/A2.02%2.67%2.39%
1 Month PerformanceN/A7.86%8.82%6.05%
1 Year PerformanceN/A176.00%31.44%13.60%

Reviva Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVPHW
Reviva Pharmaceuticals
N/A$0.06
+0.7%
N/A-77.7%$0.00N/A0.005Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+8.2%
N/A-42.3%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+4.5%
N/AN/A$0.00N/A0.002Gap Up
High Trading Volume
AIMDW
Ainos
N/A$0.16
+6.9%
N/A+67.4%$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$2.50
+15.2%
N/A-35.8%$0.00$585.60M0.004Positive News
Gap Up
High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
+27.7%
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.09
+1.9%
N/A+75.2%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.02
+1.0%
N/A-93.9%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.18
+100.0%
N/A-74.7%$0.00N/A0.008Positive News
Short Interest ↑
CELUW
Celularity
N/A$0.04
-33.3%
N/A+122.2%$0.00$54.22M0.00220Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:RVPHW) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners